Clinical Trial Update: Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study

View source ↗

Summary

This ClinicalTrials.gov update reports termination of the Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study, a tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Down Syndrome

Snippet

Sponsor: University of Colorado, Denver | Conditions: Alzheimer Disease, Down Syndrome | Status: TERMINATED